P04
Newborn affected by noxious substances transmitted via placenta or breast milk
Choose the additional character
P04 needs more characters to be billable. Pick the specific code below.
- P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryBillable
- P04.1Newborn affected by other maternal medicationMore levels
- P04.2Newborn affected by maternal use of tobaccoBillable
- P04.3Newborn affected by maternal use of alcoholBillable
- P04.4Newborn affected by maternal use of drugs of addictionMore levels
- P04.5Newborn affected by maternal use of nutritional chemical substancesBillable
- P04.6Newborn affected by maternal exposure to environmental chemical substancesBillable
- P04.8Newborn affected by other maternal noxious substancesMore levels
- P04.9Newborn affected by maternal noxious substance, unspecifiedBillable
This code does not map to a risk-adjusting HCC in the loaded models.
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
nonteratogenic effects of substances transmitted via placenta
congenital malformations (Q00-Q99) encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-) neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4) newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
any current condition in newborn, if applicable
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) tetanus neonatorum (A33)
Codes from this chapter are for use on newborn records only, never on maternal records
Official Guidelines for P04
FY 2026 ›Subsections
- I.C.16.aGeneral Perinatal Rules
- I.C.16.bObservation and Evaluation of Newborns for Suspected
- I.C.16.cCoding Additional Perinatal Diagnoses
- I.C.16.dPrematurity and Fetal Growth Retardation
- I.C.16.eLow birth weight and immaturity status
- I.C.16.fBacterial Sepsis of Newborn
- I.C.16.gStillbirth
- I.C.16.hCOVID-19 Infection in Newborn